Reasons to Retain Inari Medical Stock in Your Portfolio for Now [Yahoo! Finance]
Inari Medical, Inc. (NARI)
Company Research
Source: Yahoo! Finance
NARI is well-poised for growth on the back of a huge market opportunity for its products and its commitment to understanding the venous system. However, its dependency on the adoption of products is concerning. Shares of this Zacks Rank #3 (Hold) company have lost 29.2% year to date against the industry's 9.2% growth. The S&P 500 Index has risen 16.3% in the same time frame. NARI, with a market capitalization of $2.63 billion, is a commercial-stage medical device company. It seeks to develop products for treating and changing the lives of patients suffering from venous diseases. The company's negative earnings yield of 1.6% compares favorably with the industry's (-5.3%). It delivered a trailing four-quarter average earnings surprise of 35.80%. Image Source: Zacks Investment Research What's Driving NARI's Performance? Inari Medical's top-line growth is primarily driven by its ClotTriever and FlowTriever products that target the venous thromboembolism (VTE) markets (with sig
Show less
Read more
Impact Snapshot
Event Time:
NARI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NARI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NARI alerts
High impacting Inari Medical, Inc. news events
Weekly update
A roundup of the hottest topics
NARI
News
- Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Long-Term NARI Shareholders to Contact the FirmGlobeNewswire
- Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Stifel Nicolaus. They set a "hold" rating and a $50.00 price target on the stock.MarketBeat
- Kaskela Law LLC Announces Shareholder Investigation of Inari Medical, Inc. (NASDAQ: NARI) and Encourages Investors to Contact the FirmBusiness Wire
- Inari Medical, Inc. (NASDAQ: NARI) was upgraded by analysts at Leerink Partnrs to a "hold" rating.MarketBeat
- Inari Medical, Inc. (NASDAQ: NARI) is now covered by analysts at Leerink Partners. They set a "market perform" rating and a $47.00 price target on the stock.MarketBeat
NARI
Earnings
- 7/30/24 - Miss
NARI
Sec Filings
- 9/18/24 - Form 4
- 9/13/24 - Form 4
- 9/12/24 - Form 144
- NARI's page on the SEC website